Shopping Cart

G20 pushes for more COVID support for developing nations

At a 2-day G20 health ministers meeting in Rome over the weekend, officials passed a declaration voicing more COVID-19 support for poorer countries, but so far, no new pledges were announced. In other news, global COVID-19 cases have topped 220 million, with continued surges in Southeast Asia and Oceania among the headlines. Hopes remain for […]

mRNA COVID vaccines not tied to serious side effects

mRNA COVID-19 vaccines were not associated with significantly higher rates of 23 serious adverse events 1 to 21 days after receiving one or two doses than after 22 to 42 days, finds an interim analysis of surveillance safety data involving millions of people today in JAMA. No association between the vaccines and the specified outcomes […]

News Scan for Sep 03, 2021

Survey shows COVID-19 reduced AMR resources across 73 countries A survey across 73 countries assessing the impact of COVID-19 on the prevention and control of antimicrobial resistance (AMR) highlights reduced availability of nursing, medical, and public health staff for AMR efforts. The study was published today in the Journal of Antimicrobial Chemotherapy. The survey, conducted […]

COVID-19 Scan for Sep 03, 2021

Vaccine less protective but very beneficial vs Delta SARS-CoV-2 variant COVID-19 vaccine effectiveness (VE) against the Delta (B1617.2) variant was 65% in those fully vaccinated, according to a population-based study in Norway. The results, published in Eurosurveillance yesterday, looked at 4,204,859 infected adults without previous COVID-19 from mid-April to mid-August. Of the cohort, 0.13% had […]

Study: Vaccines slash long-haul COVID, hospital rates

The odds of long COVID-19 fall by more than half after two doses of vaccine, the risk of hospitalization drops by more than two-thirds, and breakthrough infections are nearly twice as likely to be asymptomatic, according to a UK study yesterday in The Lancet Infectious Diseases. The prospective case-control study, led by King’s College London […]

COVID long-haulers may be at risk for severe kidney disease

COVID-19 long-haulers—even those who experienced mild cases—are at significantly increased risk for substantial declines in kidney function, such as organ damage and chronic and end-stage kidney disease (ESKD), according to a study today in the Journal of the American Society of Nephrology. Long COVID-19 consists of lung and other organ dysfunction and symptoms for months […]

Study: Lifting state eviction bans puts residents at risk for COVID

A study yesterday in JAMA Network Open reveals that adult residents of US states that lifted COVID-19 eviction moratoria were at increased risk for SARS-CoV-2 infection 5 to 12 weeks later, compared with residents of states where the bans were still in place. From Mar 13 to Sep 4, 2020, 43 states and Washington, DC, […]

ASP Scan (Weekly) for Aug 27, 2021

Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans Study indicates stewardship helped reduce pediatric vancomycin use A quality improvement (QI) program combining clinician education, clear and concise recommendations, and decision support was associated with a safe reduction in vancomycin use in a pediatric intensive care unit (PICU), researchers reported today in Pediatrics. To reduce […]

News Scan for Aug 27, 2021

COVID-19 infection tied to much higher clot risk than vaccination The risk of blood clots is higher following COVID-19 infection than after vaccination, researchers based at Oxford University reported today in BMJ. Earlier this year, a number of countries identified rare thrombocytopenia and thromboembolic events in people who had received adenovirus-based vaccines, which resulted in […]

FDA works to mitigate shortage of quit-smoking drug

In July and August Pfizer voluntarily recalled a total of 16 lots of its smoking-cessation drug, Chantix (varenicline), due to unacceptably high levels of the carcinogen N-nitroso-varenicline, and the Food and Drug Administration (FDA) has taken steps to address the shortage. The company still hasn’t publicly announced any resolution timeline for its shortage, and a […]

en_USEnglish